Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN158,961590,58
Msft-0,47
Nokia9,3649,3861,85
IBM3,38
Mercedes-Benz Group AG46,65546,67-2,25
PFE-0,04
10.09.2026 1:38:55
Indexy online
AD Index online
select
AD Index online
 

  • 09.09.2026 22:00:00
Neogen Corp (NEOG.O, NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
11,92 0,29 0,04 62 582 416
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiNeogen Corp
TickerNEOG
Kmenové akcie:Ordinary Shares
RICNEOG.O
ISIN-
Poslední známé roční výsledky31.05.2026
Poslední známé čtvrtletní výsledky31.05.2026
Počet zaměstnanců k 31.05.2026 2 636
Akcie v oběhu k 04.08.2026 218 106 005
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice620 Lesher Pl
MěstoLANSING
PSČ48912-1509
ZeměUnited States
Kontatní osobaScott Gleason
Funkce kontaktní osobyInvestor Relations
Telefon15 173 729 200
Fax15173722006

Business Summary: Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.
Financial Summary: BRIEF: For the fiscal year ended 31 May 2026, Neogen Corp revenues decreased 3% to $870.4M. Net loss decreased 99% to $7.9M. Revenues reflect Animal Safety segment decrease of 11% to $229.3M, Domestic segment decrease of 5% to $425.1M, International segment decrease of 1% to $445.3M. Lower net loss reflects Food Safety segment income totaling $63.4M vs. loss of $985.7M, Animal Safety segment income increase from $7.2M to $24.5M.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSIn-Vitro Diagnostic Substance Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSBiological Product (except Diagnostic) Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSPesticide and Other Agricultural Chemical Manufacturing
NAICS2007In-Vitro Diagnostic Substance Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Biological Product (exc Diagnostic) Mfg
NAICS2007Electromedical Apparatus Mfg
NAICS2007Pesticide and Other Agricultural Chemical Manufacturing
NAICS1997InVitro Diagnostic Substance Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Biological Product (except Diagnostic) Manufacturing
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Pesticide and Other Agricultural Chemical Manufacturing
SICDiagnostic Substances
SICPharmaceutical Preparations
SICBiological Prod's Not Diagnostic
SICElectromedical Equipment
SICAgricultural Chemicals, Nec



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive OfficerMikhael Nassif5011.08.202511.08.2025
Chief Financial Officer, Senior Vice PresidentR. Bryan Riggsbee5603.11.202503.11.2025
Chief Operating OfficerDavid Naemura5703.11.202502.01.2023
Senior Vice President, General Manager - Global Food SafetyTamara Ranalli5407.01.202607.01.2026
Chief Legal & Compliance Officer, Board SecretaryJennifer Stacey6208.04.202608.04.2026